MeSH term
Frequency | Condition_Probility | Amino Acid Motifs | 3 | 0.0 |
Animals | 26 | 0.0 |
Endocytosis/*physiology | 3 | 2.0 |
Humans | 35 | 0.0 |
Protein Binding | 10 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Protein Conformation | 2 | 0.0 |
*Chromosomes, Human, Pair 12 | 2 | 0.0 |
*Chromosomes, Human, Pair 5 | 3 | 1.0 |
Receptor, Platelet-Derived Growth Factor beta/*genetics | 2 | 28.0 |
*Translocation, Genetic | 3 | 0.0 |
Actins/*metabolism | 2 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Blotting, Western | 4 | 0.0 |
Clathrin/*metabolism | 2 | 5.0 |
DNA/metabolism | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Endocytosis | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Nerve Tissue Proteins/*metabolism | 2 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Rats | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Caspases/metabolism | 3 | 0.0 |
Carrier Proteins/*genetics | 4 | 0.0 |
Comparative Study | 6 | 0.0 |
*DNA-Binding Proteins | 12 | 0.0 |
Mice | 16 | 0.0 |
Nerve Tissue Proteins/*genetics | 3 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
Base Sequence | 8 | 0.0 |
Carrier Proteins/genetics/metabolism/*physiology | 2 | 12.0 |
Cell Line, Transformed | 2 | 0.0 |
Huntington Disease/*metabolism | 2 | 20.0 |
Male | 9 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Sequence Analysis, Protein | 2 | 1.0 |
Tumor Cells, Cultured | 3 | 0.0 |
COS Cells | 5 | 0.0 |
Cell Line | 5 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Mutation | 4 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Transfection | 2 | 0.0 |
Carrier Proteins/*genetics/metabolism | 2 | 0.0 |
Fungal Proteins/genetics | 2 | 1.0 |
Helminth Proteins/genetics | 2 | 11.0 |
*Saccharomyces cerevisiae Proteins | 4 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Leukemia, Myelomonocytic, Chronic/*genetics | 2 | 20.0 |
Phosphorylation | 2 | 0.0 |
Receptor, Platelet-Derived Growth Factor beta | 2 | 11.0 |
Receptors, Platelet-Derived Growth Factor/*genetics | 2 | 18.0 |
*DNA-(Apurinic or Apyrimidinic Site) Lyase | 2 | 5.0 |
English Abstract | 2 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Gene Expression | 2 | 0.0 |
Huntington Disease/*genetics | 2 | 4.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Female | 3 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Phenotype | 3 | 0.0 |
Receptor, Epidermal Growth Factor/metabolism | 2 | 0.0 |
Spine/*abnormalities | 2 | 22.0 |
Tissue Distribution | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Transferrin/metabolism | 2 | 1.0 |
Apoptosis | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
